Literature DB >> 25783523

A comparison of four embedded validity indices for the RBANS in a memory disorders clinic.

Daniel Paulson1, Michael David Horner2, David Bachman3.   

Abstract

This examination of four embedded validity indices for the Repeated Battery for the Assessment of Neuropsychological Status (RBANS) explores the potential utility of integrating cognitive and self-reported depressive measures. Examined indices include the proposed RBANS Performance Validity Index (RBANS PVI) and the Charleston Revised Index of Effort for the RBANS (CRIER). The CRIER represented the novel integration of cognitive test performance and depression self-report information. The sample included 234 patients without dementia who could be identified as having demonstrated either valid or invalid responding, based on standardized criteria. Sensitivity and specificity for invalid responding varied widely, with the CRIER emerging as the best all-around index (sensitivity = 0.84, specificity = 0.90, AUC = 0.94). Findings support the use of embedded response validity indices, and suggest that the integration of cognitive and self-report depression data may optimize detection of invalid responding among older Veterans.
© The Author 2015. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Aging; Assessment; Cognitive evaluation; Effort testing; Index validation; Malingering; Response validity

Mesh:

Year:  2015        PMID: 25783523     DOI: 10.1093/arclin/acv009

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  2 in total

1.  RBANS Validity Indices: a Systematic Review and Meta-Analysis.

Authors:  Robert D Shura; Timothy W Brearly; Jared A Rowland; Sarah L Martindale; Holly M Miskey; Kevin Duff
Journal:  Neuropsychol Rev       Date:  2018-05-16       Impact factor: 7.444

2.  Comparison of conventional and actuarial neuropsychological criteria for mild cognitive impairment in a clinical setting.

Authors:  Stephanie Fountain-Zaragoza; Sarah Ellen Braun; Michael David Horner; Andreana Benitez
Journal:  J Clin Exp Neuropsychol       Date:  2021-12-28       Impact factor: 2.475

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.